advanced search
ACCU-BREAK’S INNOVATIVE TABLET TECHNOLOGY – 2016 ADVANCEMENTS
GI/ORAL
Dr David Beach
ACCU-BREAK’S INNOVATIVE TABLET TECHNOLOGY – 2016 ADVANCEMENTS
David Beach provides a run-down of Accu-Break Pharmaceuticals’ tablet technologies which, among other benefits, allow patients to split tablets readily and reliably.
AN INNOVATIVE SMART ORAL DELIVERY TECHNOLOGY FOR PROTEINS AND PEPTIDES
GI/ORAL
Hans Baer
Evonik
AN INNOVATIVE SMART ORAL DELIVERY TECHNOLOGY FOR PROTEINS AND PEPTIDES
Andrea Engel, Anne Benedikt and Hans Baer explain how their recently introduced new modular platform technology for improving the oral bioavailability of peptides may offer a feasible solution to the problem of compliance with peptide drugs.
THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION
GI/ORAL
Dr Cory Berkland
THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION
Cory Berkland and Nathan Dormer look at what controlled-release powder delivery systems can offer, noting that a rising number of pharmaceutical companies and manufacturing organisations are incorporating controlled-release powder manufacturing to their portfolios.
DIAL THE DOSE: A CLEVER DISPENSER FOR NON-STERILE LIQUIDS
GI/ORAL
Paul Wismer
Stevanato Group
DIAL THE DOSE: A CLEVER DISPENSER FOR NON-STERILE LIQUIDS
Paul Wismer explains how Balda's Dial-the-Dose product can help  avoid the dangers of accidental overdose from using teaspoon- or tablespoon-based instructions for liquid medications,  highlighted in several reports and studies, by improving the accuracy of liquid dosing.
THIN FILM EVOLVES TO LEVERAGE MUCOSAL DRUG DELIVERY BENEFITS
GI/ORAL
Megan Greth
THIN FILM EVOLVES TO LEVERAGE MUCOSAL DRUG DELIVERY BENEFITS
Megan Greth and Scott Barnhart describe how thin film drug delivery systems are growing in importance as the benefits, such as improved drug bioavailability, reduced adverse events and avoidance of the first pass metabolism, are increasingly being recognised.
NOVEL ORAL DRUG DELIVERY: INNOVATING TO SIMPLIFY
GI/ORAL
Rashmi Nair
NOVEL ORAL DRUG DELIVERY: INNOVATING TO SIMPLIFY
Rashmi Nair and Praveen Raheja use case studies to illustrate their company’s approach to simplifying existing oral drug delivery systems, including osmotic and matrix tablet technologies.
A NOVEL APPROACH TO THE ORAL DELIVERY OF BIOLOGICS, PEPTIDES AND ANTIBODIES
EXPERT VIEW
Mir Imran
A NOVEL APPROACH TO THE ORAL DELIVERY OF BIOLOGICS, PEPTIDES AND ANTIBODIES
Mir Imran provides an exclusive update on his company's groundbreaking robotic Auto-Pill™, which delivers a pain-free intestinal injection using a dissolvable needle made from materials that can be absorbed or easily passed out of the body. 
ORAL THIN FILMS – REALMS OF POSSIBILITY?
GI/ORAL
Dr Rick Chan
LTS
ORAL THIN FILMS – REALMS OF POSSIBILITY?
Rick Chan, PhD, Executive Scientific Officer, LTS Lohmann Therapy Systems, discusses the fundamentals of transmucosal absorption and how formulation effort and the drug properties influence drug absorption in the buccal cavity.
WHY ORAL DISINTEGRATING TABLETS?
GI/ORAL
Dr Carmen Popescu
Roquette
WHY ORAL DISINTEGRATING TABLETS?
Carmen Popescu provides an overview of the Orally Disintegrating Tablet (ODT) landscape, describing how these dosage forms can be used to improve and differentiate drug products, different manufacturing methods and how this class of oral delivery system might be applied in the future.
METHODOLOGIES FOR DEVELOPING s-SEDDS
GI/ORAL
Dr John Tillotson
METHODOLOGIES FOR DEVELOPING s-SEDDS
John Tillotson looks at the various methods available for manufacturing solid self-emulsifying drug delivery systems (s-SEDDS) and explores future possibilities of optimising these methods, which are growing in popularity as they offer advantages over liquids.
A BLUETOOTH-CONNECTED WEARABLE, ON-BODY INJECTOR
CONNECTIVITY
Mike Hooven
Enable Injections
A BLUETOOTH-CONNECTED WEARABLE, ON-BODY INJECTOR
In this article, we explore the vast potential for improving patient care that comes from adding connectivity to devices that deliver biotherapeutics for the treatment of chronic conditions.
IS YOUR WIRELESS CONNECTED DEVICE SECURE?
EXPERT VIEW
Jamie Kendall
Key Tech
IS YOUR WIRELESS CONNECTED DEVICE SECURE?
Jamie Kendall uses an example of a wireless system architecture to explain the three common cybersecurity vulnerabilities, and highlights the importance of proper implementation early on in the design process to mitigate these risks.
MATHIAS ROMACKER, PFIZER
INTERVIEW
Mathias Romacker
MATHIAS ROMACKER, PFIZER
Mathias Romacker shares his thoughts on the emergence of connectivity in drug delivery devices, he explains why he thinks the buzz around connectivity in delivery systems is more than just hype and describes the trends in the pharma sector that mean it makes sense now to connect up devices.
CONNECTED INHALERS MAKING A REAL IMPACT ON RESPIRATORY OUTCOMES
CONNECTIVITY
Garth Sutherland
Adherium
CONNECTED INHALERS MAKING A REAL IMPACT ON RESPIRATORY OUTCOMES
Garth Sutherland describes the problem of chronic non-adherence in asthma and COPD, how Adherium’s Smartinhaler™ solutions have proved themselves in the clinic, and why now is the time to move to real-world scale.
COMPANY SHOWCASE: SHL
CONNECTIVITY
SHL Medical
COMPANY SHOWCASE: SHL
SHL Group, the world’s largest privately owned designer, developer and manufacturer of advanced drug delivery systems, has been recently venturing into the field of connected devices.
SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED
INTERVIEW
Simon Michel
Ypsomed
SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED
Simon Michel talks about his vision for how the connected world of drug delivery devices will evolve, and Ypsomed’s central role within it.
CONNECTED HEALTH: THE FUTURE OF EFFECTIVE DRUG DELIVERY
CONNECTIVITY
Dr Nicolas Brandes
West Pharmaceutical Services
CONNECTED HEALTH: THE FUTURE OF EFFECTIVE DRUG DELIVERY
Chris Evans and Nicolas Brandes both of West, set the company's movement into connected health in the context of trends in the pharmaceutical industry. They introduce their partnership with HealthPrize.
CONNECTED COMBINATION PRODUCTS: PAST, PRESENT & FUTURE
EXPERT VIEW
Napoleon Monroe
CONNECTED COMBINATION PRODUCTS: PAST, PRESENT & FUTURE
Napoleon Monroe provides an overview of connected health with a focus on drug delivery systems, beginning by showing that connected health has not suddenly emerged out of nowhere but, rather, it has been developing and evolving over many decades, even centuries.
SMART PILL DISPENSER – A NEW TOOL FOR IMPROVING PATIENT ADHERENCE
CONNECTIVITY
Paul Wismer
Stevanato Group
SMART PILL DISPENSER – A NEW TOOL FOR IMPROVING PATIENT ADHERENCE
Non-adherence by patients to dosing regimens is a major problem and it is estimated that around 50% of people with chronic disease do not take their medications regularly. This has major costs not only financially but also in increased rates of complications and higher morbidity and mortality.
THE DRUG DELIVERY DEVICE AND CONNECTIVITY CHALLENGE
CONNECTIVITY
Neil Williams
THE DRUG DELIVERY DEVICE AND CONNECTIVITY CHALLENGE
Neil Williams offers insights into the challenges and experiences of developing a complete connected system including injection device, app, cloud storage, integration engine and dashboarding tool, and what to look for in a partner, to help deliver connected health devices, apps and a strategic platform.
THE MULTIPLE VALUES OF INTEGRATED SOLUTIONS
CONNECTIVITY
Eric Dessertenne
Biocorp
THE MULTIPLE VALUES OF INTEGRATED SOLUTIONS
Arnaud Guillet and Eric Dessertenne, both of Biocorp outline the potential value of the data that can be collected from integrated devices, not only for pharma companies but also for patients and payers.
THE INDUSTRIAL REVOLUTION OF MEDICAL DEVICES
EXPERT VIEW
Thomas Olesen
THE INDUSTRIAL REVOLUTION OF MEDICAL DEVICES
Thomas Olesen provides an overview of the digitalisation of healthcare, and the current status, hurdles and potential benefits of connected devices, from the perspective of a digital technology company.
EMBRACING THE FUTURE: CONNECTED DRUG DELIVERY SOLUTIONS
CONNECTIVITY
SHL Medical
EMBRACING THE FUTURE: CONNECTED DRUG DELIVERY SOLUTIONS
SHL Group explore the opportunities that the advance of digital health can bring to pharma companies, using a connected device solution to illustrate how connectivity can improve adherence to medication.
ADVANTAGES OF USING AN ELECTRONIC INJECTOR FOR DUAL CHAMBER CARTRIDGES
INJECTION
Bjarne Sørensen
ADVANTAGES OF USING AN ELECTRONIC INJECTOR FOR DUAL CHAMBER CARTRIDGES
Bjarne Sørensen explores the benefits offered by an alternative technology – the electronic injector – and how it can be used to incorporate likely future requirements such as connectivity and reduced packaging.

See what ondrugdelivery's readers and contributors think


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Abby Lockwood Opus Strategy photo
Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.


Top